SHARx Hires Andrew D. Crawford as President
01 Mayo 2024 - 9:00AM
Business Wire
Prescription Industry Veteran Enhances
Management Ranks
SHARx, one of the nation’s fastest-growing patient advocacy
corporations, announced the hiring of Andrew D. Crawford as
President. Crawford previously served as the Chief Executive
Officer of RxLogic, where he led the company through its start-up
phases and into high-growth mode. At SHARx he will report to CEO
Corey Durbin and oversee the commercial operations of the firm as
it continues on its high-growth trajectory.
“As SHARx has grown from the seed of an idea into one of the
nation’s leading patient advocacy companies, the need for a
President with Drew’s experience has become clear,” said CEO Corey
Durbin. “His long history of managing the growth of pharmaceutical
services companies in various stages of their development will
serve us well as we transition into the next phase of our rapid
growth.”
Prior to his work at RxLogic, Crawford led business development
at Maxor National Pharmacy Services with special focus on the 340B
space, was the CEO of pharmacy benefit administrator Benecard PDF
and spent considerable time at CVS Caremark, where he was
responsible for all underwriting, analytics and outcomes operations
of the company’s PBM, specialty and disease management
businesses.
“Drew’s experience across many different companies and aspects
of the complex pharmaceutical industry will allow him to help SHARx
better serve our clients and members,” added Durbin. “Creating
alternate access to high-cost and specialty medications is an
increasingly important part of the American healthcare system and
Drew knows this as well as anyone.”
Crawford said of his appointment to SHARx, “SHARx provides
critical access to high-cost and specialty medications that is
sorely lacking in the healthcare industry today. I look forward to
helping Corey and the team ensure that everyone has access to these
life-saving and life-altering medications at a reasonable
cost.”
About:
St. Louis-based SHARx is a 90-person patient advocacy
company working to help underinsured members gain access to the
life-saving and life-changing medications they need at an
affordable price. For more information, please visit
www.sharxplan.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501492214/en/
Alex Dudley alex@cloudbreakcommunications.com 917.596.1445